Results 141 to 150 of about 35,241 (222)

FGFR2 Gene Amplification [PDF]

, 2020
openaire   +1 more source

DyVarMap: Integrating Conformational Dynamics and Interpretable Machine Learning for Cancer-Associated Missense Variant Classification in FGFR2. [PDF]

Bioengineering (Basel)
Lian Y, Shehu A.
europepmc   +1 more source

FGFR2 Fusion Positive [PDF]

, 2020
openaire   +1 more source

Correction: Nishikubo et al. FGFR2 Might Be a Promising Therapeutic Target for Some Solid Tumors: Analysis of 1312 Cancers with FGFR2 Abnormalities. Int. J. Mol. Sci. 2025, 26, 10777. [PDF]

Int J Mol Sci
Nishikubo H, Ma D, Sano T, Imanishi D, Sakuma T, Fan C, Yamamoto Y, Yamamori M, Yashiro M.   +8 more
europepmc   +1 more source

FGFR2 NP_000132.3:p.N549K [PDF]

, 2020
openaire   +1 more source

GALNT3 is a novel target driving lymphomagenesis via O-glycosylation of FGFR2. [PDF]

Cell Commun Signal
Sun R, Wang W, Gao Y, Aximujiang K, Li Y, Innocent A, Xu Z, Ma J.   +7 more
europepmc   +1 more source

FGFR2 wt Allele [PDF]

, 2020
openaire   +1 more source

Molecular Testing for Intrahepatic Cholangiocarcinoma: What, When, How? [PDF]

J Gastrointest Cancer
Barsch M, Dopfer EP, Schultheis AM, Quante M.   +3 more
europepmc   +1 more source

FGFR2 NP_000132.3:p.K659E [PDF]

, 2020
openaire   +1 more source

FGF1-FGFR2 axis regulated by nuclear receptor RORγ represents an effective strategy in intrahepatic cholangiocarcinoma. [PDF]

Cell Death Discov
Gu Z, Wang X, Wang H, Wang J, Huang Z, Pan D, Zhang Z, Zeng Y, Cai G, Sun H, Zheng J, Nie Y, Zhang Q, Li H, Chan FL, Wang J, Zheng J, Fan Y.   +17 more
europepmc   +1 more source